OHR PHARMACEUTICAL INC's ticker is OHRP and the CUSIP is 67778H200. A total of 33 filers reported holding OHR PHARMACEUTICAL INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $3,000 | -50.0% | 33,472 | -2.9% | 0.00% | – |
Q3 2018 | $6,000 | -14.3% | 34,472 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | -22.2% | 34,472 | -21.2% | 0.00% | – |
Q1 2018 | $9,000 | -85.9% | 43,759 | +26.9% | 0.00% | – |
Q4 2017 | $64,000 | +156.0% | 34,472 | 0.0% | 0.00% | – |
Q3 2017 | $25,000 | +4.2% | 34,472 | -7.9% | 0.00% | – |
Q2 2017 | $24,000 | -20.0% | 37,412 | +2.8% | 0.00% | – |
Q1 2017 | $30,000 | -40.0% | 36,399 | +8.7% | 0.00% | – |
Q4 2016 | $50,000 | -50.5% | 33,472 | -6.5% | 0.00% | – |
Q3 2016 | $101,000 | -38.4% | 35,811 | -40.4% | 0.00% | – |
Q2 2016 | $164,000 | -13.7% | 60,069 | +1.3% | 0.00% | – |
Q1 2016 | $190,000 | -26.4% | 59,312 | +41.1% | 0.00% | – |
Q4 2015 | $258,000 | +196.6% | 42,045 | +34.1% | 0.00% | – |
Q3 2015 | $87,000 | +10.1% | 31,363 | +0.2% | 0.00% | – |
Q2 2015 | $79,000 | -65.8% | 31,313 | -65.5% | 0.00% | – |
Q1 2015 | $231,000 | -71.7% | 90,725 | -7.0% | 0.00% | – |
Q4 2014 | $815,000 | +19.0% | 97,560 | +3.2% | 0.00% | – |
Q3 2014 | $685,000 | -57.1% | 94,569 | -43.7% | 0.00% | – |
Q2 2014 | $1,598,000 | – | 168,030 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GARRISON BRADFORD & ASSOCIATES INC | 85,415 | $55,000 | 0.05% |
Leisure Capital Management | 65,199 | $42,000 | 0.04% |
SABBY MANAGEMENT, LLC | 681,300 | $436,000 | 0.03% |
Cutter & CO Brokerage, Inc. | 44,975 | $29,000 | 0.01% |
SALZHAUER MICHAEL | 35,715 | $23,000 | 0.01% |
Cannell & Co. | 292,858 | $187,000 | 0.01% |
Tower Research Capital LLC (TRC) | 70,933 | $45,000 | 0.01% |
JT Stratford LLC | 10,000 | $6,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 15,086 | $10,000 | 0.00% |
STONERIDGE INVESTMENT PARTNERS LLC | 14,952 | $10,000 | 0.00% |